Danielle P. Vieira
Federal University of Rio de Janeiro
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Danielle P. Vieira.
Infection and Immunity | 2008
Rafael D. Mesquita; Alan Brito Carneiro; André Báfica; Felipe Gazos-Lopes; Christina Maeda Takiya; Thaïs Souto-Padrón; Danielle P. Vieira; Antonio Ferreira-Pereira; Igor C. Almeida; Rodrigo T. Figueiredo; Bárbara N. Porto; Marcelo T. Bozza; Aurélio V. Graça-Souza; Angela H. Lopes; Georgia C. Atella; Mário A.C. Silva-Neto
ABSTRACT Trypanosoma cruzi, the etiological agent of Chagas disease, is transmitted by bug feces deposited on human skin during a blood meal. However, parasite infection occurs through the wound produced by insect mouthparts. Saliva of the Triatominae bug Rhodnius prolixus is a source of lysophosphatidylcholine (LPC). Here, we tested the role of both triatomine saliva and LPC on parasite transmission. We show that vector saliva is a powerful inducer of cell chemotaxis. A massive number of inflammatory cells were found at the sites where LPC or saliva was inoculated into the skin of mice. LPC is a known chemoattractant for monocytes, but neutrophil recruitment induced by saliva is LPC independent. The preincubation of peritoneal macrophages with saliva or LPC increased fivefold the association of T. cruzi with these cells. Moreover, saliva and LPC block nitric oxide production by T. cruzi-exposed macrophages. The injection of saliva or LPC into mouse skin in the presence of the parasite induces an up-to-sixfold increase in blood parasitemia. Together, our data suggest that saliva of the Triatominae enhances T. cruzi transmission and that some of its biological effects are attributed to LPC. This is a demonstration that a vector-derived lysophospholipid may act as an enhancing factor of Chagas disease.
Biochemical and Biophysical Research Communications | 2002
Mário A.C. Silva-Neto; Alan Brito Carneiro; Danielle P. Vieira; Rafael D. Mesquita; Angela H. Lopes
Herpetomonas muscarum muscarum is a flagellate parasite of the family Trypanosomatidae, whose cell differentiation can be triggered by the lipid mediator, PAF. In this study we demonstrate for the first time that PAF effect relies on the activation of casein kinase 2 (CK2). The classical antagonist of PAF receptor, WEB 2086, abrogated PAF-enhanced CK2 activity. CK2 activation by PAF was also inhibited when parasite extracts were assayed in the presence of modulators of PKC, MAPK, and both Ser/Thr and Tyr phosphatases. Finally, a cell permeable inhibitor of CK2 (DRB) suppressed PAF-induced cell differentiation in a dose-dependent manner.
PLOS Neglected Tropical Diseases | 2014
Felipe Gazos-Lopes; Mauricio M. Oliveira; Lucas V. B. Hoelz; Danielle P. Vieira; Alexandre F. Marques; Ernesto S. Nakayasu; Marta T. Gomes; Nasim G. Salloum; Pedro G. Pascutti; Thaïs Souto-Padrón; Robson Q. Monteiro; Angela H. Lopes; Igor C. Almeida
Background Trypanosoma cruzi is the causative agent of the life-threatening Chagas disease, in which increased platelet aggregation related to myocarditis is observed. Platelet-activating factor (PAF) is a potent intercellular lipid mediator and second messenger that exerts its activity through a PAF-specific receptor (PAFR). Previous data from our group suggested that T. cruzi synthesizes a phospholipid with PAF-like activity. The structure of T. cruzi PAF-like molecule, however, remains elusive. Methodology/Principal findings Here, we have purified and structurally characterized the putative T. cruzi PAF-like molecule by electrospray ionization-tandem mass spectrometry (ESI-MS/MS). Our ESI-MS/MS data demonstrated that the T. cruzi PAF-like molecule is actually a lysophosphatidylcholine (LPC), namely sn-1 C18:1(delta 9)-LPC. Similar to PAF, the platelet-aggregating activity of C18:1-LPC was abrogated by the PAFR antagonist, WEB 2086. Other major LPC species, i.e., C16:0-, C18:0-, and C18:2-LPC, were also characterized in all T. cruzi stages. These LPC species, however, failed to induce platelet aggregation. Quantification of T. cruzi LPC species by ESI-MS revealed that intracellular amastigote and trypomastigote forms have much higher levels of C18:1-LPC than epimastigote and metacyclic trypomastigote forms. C18:1-LPC was also found to be secreted by the parasite in extracellular vesicles (EV) and an EV-free fraction. A three-dimensional model of PAFR was constructed and a molecular docking study was performed to predict the interactions between the PAFR model and PAF, and each LPC species. Molecular docking data suggested that, contrary to other LPC species analyzed, C18:1-LPC is predicted to interact with the PAFR model in a fashion similar to PAF. Conclusions/Significance Taken together, our data indicate that T. cruzi synthesizes a bioactive C18:1-LPC, which aggregates platelets via PAFR. We propose that C18:1-LPC might be an important lipid mediator in the progression of Chagas disease and its biosynthesis could eventually be exploited as a potential target for new therapeutic interventions.
The Open Parasitology Journal | 2010
José Roberto Meyer-Fernandes; Daniela Cosentino-Gomes; Danielle P. Vieira; Angela H. Lopes
Ecto-nucleoside triphosphate diphosphohydrolases (ecto-NTPDases), also known as ecto-ATPases and/or ecto- apyrases, are integral membrane glycoproteins or soluble enzymes that are dependent on divalent cations. These ecto- enzymes are important ecto-nucleotidases that are characterized by the ability to hydrolyze nucleoside triphosphates and nucleoside diphosphates to the monophosphate form. The hydrolysis of nucleoside monophosphates to nucleosides such as adenosine may then be catalyzed by the action of ecto-5´nucleotidases. The present study reviews the sequential hy- drolysis of ATPADPAMPadenosine catalyzed by these ecto-enzymes from different trypanosomatids. These reactions participate in the salvage of purines in these parasites and simultaneously interfere with the establishment of in- fection and changes in the host immune response.
Acta Tropica | 2009
Patrícia Maria Lourenço Dutra; Danielle P. Vieira; José Roberto Meyer-Fernandes; Mário A.C. Silva-Neto; Angela H. Lopes
Leishmania tropica is one of the causative agents of cutaneous leishmaniasis. Platelet-activating factor (PAF) is a phospholipid mediator in diverse biological and pathophysiological processes. Here we show that PAF promoted a three-fold increase on ecto-protein kinase and a three-fold increase on the secreted kinase activity of L. tropica live promastigotes. When casein was added to the reaction medium, along with PAF, there was a four-fold increase on the ecto-kinase activity. When live L. tropica promastigotes were pre-incubated for 30 min in the presence of PAF-plus casein, a six-fold increase on the secreted kinase activity was observed. Also, a protein released from L. tropica promastigotes reacted with polyclonal antibodies for the mammalian CK2 alpha catalytic subunit. Furthermore, in vitro mouse macrophage infection by L. tropica was doubled when promastigotes were pre-treated for 2 h with PAF. Similar results were obtained when the interaction was performed in the presence of purified CK2 or casein. TBB and DRB, CK2 inhibitors, reversed PAF enhancement of macrophage infection by L. tropica. WEB 2086, a competitive PAF antagonist, reversed all PAF effects here described. This study shows for the first time that PAF promotes the activation of two isoforms of CK2, secreted and membrane-bound, correlating these activities to infection of mouse macrophages.
Acta Tropica | 2016
Fernando L. Dutra; Mauricio M. Oliveira; Reinaldo Sousa Dos Santos; Wagner Seixas da Silva; Daniela Sales Alviano; Danielle P. Vieira; Angela H. Lopes
The most commonly used drugs against visceral leishmaniasis are based on pentavalent antimonial compounds, which have played a fundamental role in therapy for over 70 years. However, the treatment is painful and has severe toxic side effects that can be fatal. Antimonial resistance is spreading and reaching alarming proportions. Linalool and eugenol have been shown to kill Leishmania (L.) amazonensis and Trypanosoma cruzi at low doses. In the present study, we demonstrate the effects of linalool and eugenol, components of essential oils, on Leishmania (L.) infantum chagasi, one of the causative agents of visceral leishmaniasis. We compared the effects of those compounds to the effects of glucantime, a positive control. In L. infantum chagasi killing assays, the LD50 for eugenol was 220μg/ml, and that for linalool was 550μg/ml. L. infantum chagasi was added to cultures of peritoneal mouse macrophages for four hours prior to drug treatment. Eugenol and linalool significantly decreased the number of parasites within the macrophages. Eugenol and linalool enhanced the activities of the L. infantum chagasi protein kinases PKA and PKC. Linalool also decreased L. infantum chagasi oxygen consumption. In conclusion, both linalool and eugenol promoted a decrease in the proliferation and viability of L. infantum chagasi. These effects were more pronounced during the interaction between the parasites and peritoneal mouse macrophages.
The Open Parasitology Journal | 2010
Angela H. Lopes; Marta T. Gomes; Fernando L. Dutra; Alane Beatriz Vermelho; José Roberto Meyer-Fernandes; Mário A.C. Silva-Neto; Thaïs Souto-Padrón; Danielle P. Vieira
Knowledge of cell signaling pathways in trypanosomatids is crucial for the future design of new drugs to treat diseases caused by these parasites. The publication of the complete genome sequences of three pathogenic trypanosomat- ids, Trypanosoma brucei, T. cruzi and Leishmania major, revealed numerous protein members of signaling pathways that modulate important processes, such as cell differentiation. Even so, little is known about the role that these proteins play in the physiology of trypanosomatids. This review aims to stimulate discussion on this subject to encourage further studies of the signaling pathways involved in the cell differentiation of trypanosomatids.
Parasitology Research | 2007
Igor de Almeida; Daniela Sales Alviano; Danielle P. Vieira; Péricles Barreto Alves; Arie Fitzgerald Blank; Angela H. Lopes; Celuta Sales Alviano; Maria do Socorro S. Rosa
Experimental Parasitology | 2011
Rafael Paletta-Silva; Danielle P. Vieira; Rodrigo Vieira-Bernardo; David Majerowicz; Katia C. Gondim; Marcos A. Vannier-Santos; Angela H. Lopes; José Roberto Meyer-Fernandes
Experimental Parasitology | 2011
Danielle P. Vieira; Rafael Paletta-Silva; Elvira M. Saraiva; Angela H. Lopes; José Roberto Meyer-Fernandes